Document is current
Any future updates will be listed below
-
Authors
Stroyakovski, Maria
Huo, Yunlong
Cheetham, Max J.
Javed, Abid
Cheng, Li
Lavollee, Julie
Zuza, Allan
Dubiel, Paulina
Barber, Nemean
Storey, Nathaniel
Pearse, Oliver
Gibbon, Marjorie J.
Lipworth, Samuel
Avison, Matthew B.
Feil, Edward J.
Stoesser, Nicole
Feasey, Nicholas
Santini, Joanne M.
-
Funding
Funding for this research was provided by:
EPSRC CDT in BioDesign Engineering (EP/S022856/1)
EPSRC and BBSRC Centre for Doctoral Training in Engineering Solutions for Antimicrobial Resistance (EP/Y035658/1)
National Institute for Health and Care Research (NIHR200915)
National Institute for Health and Care Research (NIHR200915)
OH-DART (MR/S004769/1)
NIHR Oxford Biomedical Research Centre
Biotechnology and Biological Sciences Research Council (BB/X511079/1)
Research England’s Higher Education Innovation Fund
University College London Friends and Alumni Association
- License Information
-
More Information
Article History
Received: 17 February 2026
Accepted: 27 August 2026
First Online: 11 September 2026
Declarations
Competing interests: J.M.S. is a Director of OptimalPhage Therapeutics Ltd. The other authors declare no competing interests.
